Your browser doesn't support javascript.
loading
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Blankenstein, Stephanie A; Bonenkamp, Johannes J; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; Blank, Christian U; Blokx, Willeke A M; Boers-Sonderen, Marye J; van den Eertwegh, Alfons J M; Franken, Margreet G; de Groot, Jan Willem B; Haanen, John B A G; Hospers, Geke A P; Kapiteijn, Ellen W; van Not, Olivier J; Piersma, Djura; van Rijn, Rozemarijn S; Suijkerbuijk, Karijn P M; van der Veldt, Astrid A M; Vreugdenhil, Gerard; Westgeest, Hans M; Wouters, Michel W J M; van Akkooi, Alexander C J.
Afiliação
  • Blankenstein SA; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. s.blankenstein@nki.nl.
  • Bonenkamp JJ; Department of Surgical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  • van den Berkmortel FWPJ; Department of Internal Medicine, Zuyderland Medical Centre Geleen-Heerlen, Sittard-Geleen, The Netherlands.
  • Blank CU; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Blokx WAM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • van den Eertwegh AJM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VU University Medical Center (VUmc), Amsterdam, The Netherlands.
  • Franken MG; Institute for Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University, Rotterdam, The Netherlands.
  • de Groot JWB; Oncology Center Isala, Isala, Zwolle, The Netherlands.
  • Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Kapiteijn EW; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.
  • van Not OJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Piersma D; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.
  • van Rijn RS; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Suijkerbuijk KPM; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • van der Veldt AAM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Vreugdenhil G; Departments of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Westgeest HM; Department of Internal Medicine, Maxima Medical Center, Veldhoven, The Netherlands.
  • Wouters MWJM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
  • van Akkooi ACJ; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Ann Surg Oncol ; 30(1): 587-588, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36319872

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda